CA Stock MarketDetailed Quotes

Sernova Biotherapeutics Inc (SVA)

Watchlist
  • 0.170
  • +0.005+3.03%
15min DelayMarket Closed May 1 16:00 ET
59.11MMarket Cap-4.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sernova Biotherapeutics Inc (SVA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jan 31, 2026
(FY)Oct 31, 2025
(Q4)Oct 31, 2025
(Q3)Jul 31, 2025
(Q2)Apr 30, 2025
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-55.94%2.12M
-52.55%15.02M
-48.84%2.4M
-51.08%3.5M
-55.84%4.33M
-52.13%4.8M
-21.82%31.66M
-60.35%4.68M
-30.36%7.15M
-0.10%9.8M
Selling and administrative expenses
-23.76%1.68M
-16.11%7.5M
-19.01%1.58M
-17.38%1.75M
-6.00%1.96M
-20.65%2.2M
6.07%8.94M
-8.10%1.96M
15.54%2.12M
-24.92%2.08M
-General and administrative expense
-23.76%1.68M
-16.11%7.5M
-19.01%1.58M
-17.38%1.75M
-6.00%1.96M
-20.65%2.2M
6.07%8.94M
-8.10%1.96M
15.54%2.12M
-24.92%2.08M
Research and development costs
-83.23%434.15K
-66.93%7.5M
-70.21%809.63K
-65.31%1.74M
-69.35%2.36M
-64.25%2.59M
-29.19%22.69M
-71.91%2.72M
-40.40%5.02M
9.69%7.71M
Depreciation amortization depletion
--0
-39.31%20.69K
-69.20%3.12K
-60.52%3.12K
-8.42%7.23K
-11.70%7.23K
8.91%34.09K
24.45%10.12K
-0.23%7.89K
2.93%7.89K
-Depreciation and amortization
--0
-39.31%20.69K
-69.20%3.12K
-60.52%3.12K
-8.42%7.23K
-11.70%7.23K
8.91%34.09K
24.45%10.12K
-0.23%7.89K
2.93%7.89K
Operating profit
55.94%-2.12M
52.55%-15.02M
48.84%-2.4M
51.08%-3.5M
55.84%-4.33M
52.13%-4.8M
21.82%-31.66M
60.35%-4.68M
30.36%-7.15M
0.10%-9.8M
Net non-operating interest income (expenses)
-125.56%-477.12K
-267.41%-729.18K
275.32%260.6K
-80.61%-541.55K
-351.42%-236.7K
-235.71%-211.53K
-113.52%-198.47K
-151.39%-148.64K
-190.08%-299.84K
-76.15%94.15K
Non-operating interest income
--0
-93.40%25.63K
-99.95%27
-99.76%131
-98.24%2.03K
-85.90%23.45K
-74.11%388.39K
-82.70%51.1K
-83.65%55.64K
-71.42%115.33K
Non-operating interest expense
103.05%477.12K
28.62%754.81K
-230.45%-260.57K
52.38%541.68K
1,026.82%238.73K
2,146.87%234.98K
1,729.64%586.86K
3,203.66%199.74K
4,706.96%355.48K
143.71%21.19K
Other net income (expenses)
127.43%185.74K
105.63%18.17K
9.73%-116.57K
86.55%-11.22K
444.22%823.08K
-626.07%-677.13K
-998.86%-322.93K
28.79%-129.13K
-1,016.75%-83.4K
-460.31%-239.11K
Gain on sale of security
127.43%185.74K
89.16%-37.05K
6.44%-120.82K
25.44%-62.18K
444.22%823.08K
-716.40%-677.13K
-1,051.37%-341.79K
28.79%-129.13K
-1,016.75%-83.4K
-460.31%-239.11K
Special income (charges)
----
192.73%55.22K
--4.25K
--50.96K
--0
--0
--18.86K
--0
--0
--0
-Gain on sale of property,plant,equipment
----
192.73%55.22K
--4.25K
--50.96K
--0
--0
--18.86K
--0
--0
--0
Income before tax
57.70%-2.41M
51.11%-15.73M
54.60%-2.25M
46.23%-4.05M
62.38%-3.74M
41.61%-5.69M
17.47%-32.19M
57.61%-4.96M
24.11%-7.54M
-6.38%-9.94M
Income tax
-1,225.00%-72K
34.73%9.43K
-885.30%-54.97K
21.12K
36.88K
6.4K
7K
7K
0
0
Earnings from equity interest net of tax
Net income
59.01%-2.33M
51.10%-15.74M
55.77%-2.2M
45.95%-4.07M
62.01%-3.78M
41.55%-5.7M
17.45%-32.19M
57.55%-4.97M
24.11%-7.54M
-6.38%-9.94M
Net income continuous operations
59.01%-2.33M
51.10%-15.74M
55.77%-2.2M
45.95%-4.07M
62.01%-3.78M
41.55%-5.7M
17.45%-32.19M
57.55%-4.97M
24.11%-7.54M
-6.38%-9.94M
Noncontrolling interests
Net income attributable to the company
59.01%-2.33M
51.10%-15.74M
55.77%-2.2M
45.95%-4.07M
62.01%-3.78M
41.55%-5.7M
17.45%-32.19M
57.55%-4.97M
24.11%-7.54M
-6.38%-9.94M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
59.01%-2.33M
51.10%-15.74M
55.77%-2.2M
45.95%-4.07M
62.01%-3.78M
41.55%-5.7M
17.45%-32.19M
57.55%-4.97M
24.11%-7.54M
-6.38%-9.94M
Diluted earnings per share
50.00%-0.01
50.00%-0.05
0.00%-0.01
50.00%-0.01
66.67%-0.01
33.33%-0.02
23.08%-0.1
75.00%-0.01
33.33%-0.02
0.00%-0.03
Basic earnings per share
50.00%-0.01
50.00%-0.05
0.00%-0.01
50.00%-0.01
66.67%-0.01
33.33%-0.02
23.08%-0.1
75.00%-0.01
33.33%-0.02
0.00%-0.03
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jan 31, 2026(FY)Oct 31, 2025(Q4)Oct 31, 2025(Q3)Jul 31, 2025(Q2)Apr 30, 2025(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -55.94%2.12M-52.55%15.02M-48.84%2.4M-51.08%3.5M-55.84%4.33M-52.13%4.8M-21.82%31.66M-60.35%4.68M-30.36%7.15M-0.10%9.8M
Selling and administrative expenses -23.76%1.68M-16.11%7.5M-19.01%1.58M-17.38%1.75M-6.00%1.96M-20.65%2.2M6.07%8.94M-8.10%1.96M15.54%2.12M-24.92%2.08M
-General and administrative expense -23.76%1.68M-16.11%7.5M-19.01%1.58M-17.38%1.75M-6.00%1.96M-20.65%2.2M6.07%8.94M-8.10%1.96M15.54%2.12M-24.92%2.08M
Research and development costs -83.23%434.15K-66.93%7.5M-70.21%809.63K-65.31%1.74M-69.35%2.36M-64.25%2.59M-29.19%22.69M-71.91%2.72M-40.40%5.02M9.69%7.71M
Depreciation amortization depletion --0-39.31%20.69K-69.20%3.12K-60.52%3.12K-8.42%7.23K-11.70%7.23K8.91%34.09K24.45%10.12K-0.23%7.89K2.93%7.89K
-Depreciation and amortization --0-39.31%20.69K-69.20%3.12K-60.52%3.12K-8.42%7.23K-11.70%7.23K8.91%34.09K24.45%10.12K-0.23%7.89K2.93%7.89K
Operating profit 55.94%-2.12M52.55%-15.02M48.84%-2.4M51.08%-3.5M55.84%-4.33M52.13%-4.8M21.82%-31.66M60.35%-4.68M30.36%-7.15M0.10%-9.8M
Net non-operating interest income (expenses) -125.56%-477.12K-267.41%-729.18K275.32%260.6K-80.61%-541.55K-351.42%-236.7K-235.71%-211.53K-113.52%-198.47K-151.39%-148.64K-190.08%-299.84K-76.15%94.15K
Non-operating interest income --0-93.40%25.63K-99.95%27-99.76%131-98.24%2.03K-85.90%23.45K-74.11%388.39K-82.70%51.1K-83.65%55.64K-71.42%115.33K
Non-operating interest expense 103.05%477.12K28.62%754.81K-230.45%-260.57K52.38%541.68K1,026.82%238.73K2,146.87%234.98K1,729.64%586.86K3,203.66%199.74K4,706.96%355.48K143.71%21.19K
Other net income (expenses) 127.43%185.74K105.63%18.17K9.73%-116.57K86.55%-11.22K444.22%823.08K-626.07%-677.13K-998.86%-322.93K28.79%-129.13K-1,016.75%-83.4K-460.31%-239.11K
Gain on sale of security 127.43%185.74K89.16%-37.05K6.44%-120.82K25.44%-62.18K444.22%823.08K-716.40%-677.13K-1,051.37%-341.79K28.79%-129.13K-1,016.75%-83.4K-460.31%-239.11K
Special income (charges) ----192.73%55.22K--4.25K--50.96K--0--0--18.86K--0--0--0
-Gain on sale of property,plant,equipment ----192.73%55.22K--4.25K--50.96K--0--0--18.86K--0--0--0
Income before tax 57.70%-2.41M51.11%-15.73M54.60%-2.25M46.23%-4.05M62.38%-3.74M41.61%-5.69M17.47%-32.19M57.61%-4.96M24.11%-7.54M-6.38%-9.94M
Income tax -1,225.00%-72K34.73%9.43K-885.30%-54.97K21.12K36.88K6.4K7K7K00
Earnings from equity interest net of tax
Net income 59.01%-2.33M51.10%-15.74M55.77%-2.2M45.95%-4.07M62.01%-3.78M41.55%-5.7M17.45%-32.19M57.55%-4.97M24.11%-7.54M-6.38%-9.94M
Net income continuous operations 59.01%-2.33M51.10%-15.74M55.77%-2.2M45.95%-4.07M62.01%-3.78M41.55%-5.7M17.45%-32.19M57.55%-4.97M24.11%-7.54M-6.38%-9.94M
Noncontrolling interests
Net income attributable to the company 59.01%-2.33M51.10%-15.74M55.77%-2.2M45.95%-4.07M62.01%-3.78M41.55%-5.7M17.45%-32.19M57.55%-4.97M24.11%-7.54M-6.38%-9.94M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 59.01%-2.33M51.10%-15.74M55.77%-2.2M45.95%-4.07M62.01%-3.78M41.55%-5.7M17.45%-32.19M57.55%-4.97M24.11%-7.54M-6.38%-9.94M
Diluted earnings per share 50.00%-0.0150.00%-0.050.00%-0.0150.00%-0.0166.67%-0.0133.33%-0.0223.08%-0.175.00%-0.0133.33%-0.020.00%-0.03
Basic earnings per share 50.00%-0.0150.00%-0.050.00%-0.0150.00%-0.0166.67%-0.0133.33%-0.0223.08%-0.175.00%-0.0133.33%-0.020.00%-0.03
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -